Abstract
Sarcoidosis is a multisystem granulomatous disease of unknown etiology and with variable presentation. Skin, lymph nodes, lungs, eyes and the central nervous system are mostly involved. Cardiac sarcoidosis (CS) is a rare condition with clinical manifestations in about 5% of patients. Since it increases the risk of acute cardiac failure, ventricular arrhythmia, conduction disturbances and even sudden death, it aggravates markedly the prognosis. The early diagnosis of CS is difficult, requiring the use of diagnostic tools such as electrocardiographic monitoring, two-dimensional echocardiography, radionuclide scan, cardiac magnetic resonance imaging, positron emission tomography and endomyocardial biopsy. Once the diagnosis of CS is established, there is a need for early corticosteroids treatment, with or without immunosuppressive therapy, to prevent deterioration of cardiac function. In patients with refractory ventricular tachyarrhythmia, markedly reduced left ventricular ejection fraction and high risk of sudden death, prophylactic insertion of a pacemaker or implantable defibrillator is recommended. We had the opportunity to treat a patient with CS and to review the currently accepted diagnostic and treatment approach.
Similar content being viewed by others
References
Iannuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis., N. Engl. J. Med., 2007, 357, 2153–2165
Dorfman T., Canales J., Farukhi I., McGuire D.K., Sarcoidosis masquerading as an acute coronary syndrome. Cardiol. Rev., 2005, 13, 256–259
Pierre-Louis B., Prasad A., Frishman W.H., Cardiac manifestations of sarcoidosis and therapeutic options. Cardiol. Rev., 2009, 17, 153–158.
Sun B.J., Lee P.H., Choi H.O., Ahn J.M, Seo J.S, Kim D.H., et al., Prevalence of echocardiographic features suggesting cardiac sarcoidosis in patients with pacemaker or implantable cardiac defibrillator. Korean Circ. J., 2011, 41, 313–320
Sohn I.S., Cardiac Sarcoidosis: Oldies but not goodies. Korean Circ J., 2011, 41, 296–298
Patel M.R., Cawley P.J., Heitner J.F., Klem I, Parker M.A, Jaroudi W.A., et al., Detection of myocardial damage in patients with sarcoidosis. Circulation, 2009, 120, 1969–1977
Nunes H., Freynet O., Naggara N., Soussan M, Weinman P, Diebold B., et al., Cardiac sarcoidosis. Semin. Respir. Crit. Care Med., 2010, 31, 428–441
Hiraga H., Yuwai K., Hiroe M., Guideline for diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary disease from the Japanese Ministry of Health and Welfare. 1993, 23–24
Mitropoulos F.A., Floudas C.S., Kanakis M.A., Vaiopoulos G.A., Cardiac sarcoidosis. Thorac. Cardiovasc. Surg., 2009, 57, 187–190
Hamzeh N.Y., Wamboldt F.S., Weinberger H.D., Management of cardiac sarcoidosis in the United States: a delphi study. Chest., 2012, 141, 154–162
Dubrey S.W., Falk R.H., Diagnosis and management of cardiac sarcoidosis. Prog. Cardiovasc. Dis., 2010, 52, 336–346
Soejima K., Yada H., The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol., 2009, 5, 578–583
Divakara Menon S.M., Chemello D., Morillo C.A., Sarcoidosis: yet another masquerader the cardiologist / electrophysiologist has to fight with. Indian Pacing Electrophysiol. J., 2010, 10, 479–485
Homsi M., Alsayed L., Safadi B., Mahenthiran J., Das M.K., Fragmented QRS complexes on 12-lead ECG: a marker of cardiac sarcoidosis as detected by gadolinium cardiac magnetic resonance imaging. Ann. Noninvasive Electrocardiol., 2009, 14, 319–326
Suzuki T., Kanda T., Kubota S., Imai S., Murata K., Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest, 1994, 106, 1021–1024
Petrović M., Vujisić-Tesić B., Boricić M., Spectrum of echocardiographic findings in patients with systemic sarcoidosis. Med. Pregl., 2005; 58Suppl 1:35–38
Hyodo E., Hozumi T., Takemoto Y., Watanabe H., Muro T., Yamagishi H., et al., Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation. Heart, 2004, 90, 1275–1280
Tellier P., Paycha F., Antony I., Nitenberg A., Valeyre D., Foult J.M., et al., Reversibility by dipyridamole of thallium 201 myocardial scan defects in patients with sarcoidosis. Am. J. Med., 1988, 85, 189–193
Nery P.B., Leung E., Birnie D.H., Arrhythmias in cardiac sarcoidosis: diagnosis and treatment. Curr. Opin. Cardiol., 2012, 27, 181–189
Futamatsu H., Suzuki J., Adachi S., Okada H., Otomo K., Ohara T., et al., Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia. Int. J. Cardiovasc. Imaging, 2006, 22, 443–448
Okayama K., Kurata C., Tawarahara K., Wakabayashi Y., Chida K., Sato A., Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest, 1995, 107, 330–334
Sekhri V., Sanal S., Delorenzo L.J., Aronow W.S., Maguire G.P., Cardiac sarcoidosis: a comprehensive review. Arch. Med. Sci., 2011, 7, 546–554
Ohira H., Tsujino I., Yoshinaga K., 18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur. J. Nucl. Med. Mol. Imaging., 2011, 38, 1773–1783
Youssef G., Leung E., Mylonas I., Nery P., Williams K., Wisenberg G., et al., The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: A Systematic review and metaanalysis including the Ontario experience. J. Nucl. Med., 2012, 53, 241–248
Mañá J., Gámez C., Molecular imaging in sarcoidosis. Curr. Opin. Pulm.Med., 2011, 17, 325–331
Sharma S., Cardiac imaging in myocardial sarcoidosis and other cardiomyopathies. Curr. Opin. Pulm. Med., 2009, 15, 507–512
Tadamura E., Yamamuro M., Kubo S., Kanao S., Saga T., Harada M., et al., Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. A.J.R. Am. J. Roentgenol., 2005, 185, 110–115
Penugonda N., Cardiac MRI in infiltrative disorders: a concise review. Curr. Cardiol. Rev., 2010, 6, 134–136
Vignaux O., Cardiac sarcoidosis: spectrum of MRI features. A.J.R. Am. J. Roentgenol., 2005, 184, 249–254
Doughan A.R., Williams B.R., Cardiac sarcoidosis. Heart, 2006, 92, 282–288
Smedema J.P., Truter R., de Klerk P.A., Zaaiman L., White L., Doubell A.F., Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography. Int. J. Cardiol., 2006, 112: 261–263
Smedema J.P., Snoep G., Marinus P.G., van Kroonenburgh M.P., van Geuns R.J., Dassen W.R., et al., Evaluation of accuracy of gadolinium enhanced cardiovascular magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis. J. Am. Coll. Cardiol. 2005, 45, 1683–1690
Ohira H., Tsujino I., Ishimaru S., Oyama N., Takei T., Tsukamoto E., et al., Myocardial imaging with 18F-Fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur. J. Nucl. Med. Mol. Imaging, 2008, 35, 933–941
Ichinose A., Otani H., Oikawa M., Takase K., Saito H., Shimokawa H., et al., MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. A.J.R. Am. J. Roentgenol, 2008, 191, 862–869
Matoh F., Satoh H., Shiraki K., Odagiri K., Saitoh T., Urushida T., et al., The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis. J. Cardiol., 2008, 51, 179–188
Stone M.E., Salter B., Fischer A., Perioperative management of patients with cardiac implantable electronic devices. Br J Anaesth. 2011, 107,Suppl 1: i16–26.
Uemura A., Morimoto S., Hiramitsu S., Kato Y., Ito T., Hishida H., Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J. 1999, 138, 299–302
Schulte W., Kirsten D., Drent M., Costabel U., Cardiac involvement in sarcoidosis. Eur. Respir. J. Monogr., 2005, 10, 130–139
Sekiguchi M., Yazaki Y., Isobe M., Hiroe M., Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc. Drugs Ther., 1996, 10, 495–510
Kim J.S, Judson M.A, Donnino R., Gold M., Cooper L.T Jr, Prystowsky E.N., et al. Cardiac sarcoidosis. Am. Heart J., 2009, 157, 9–21
Schutt A.C., Bullington W.M., Judson M.A., Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study. Respir Med. 2010, 104, 717–723
Yazaki Y., Isobe M., Hiroe M., Morimoto S., Hiramitsu S., Nakano T., et al., Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am. J. Cardiol., 2001, 88, 1006–1010
Londner C., Zendah I., Freynet O., Carton Z., Dion G., Nunes H., et al., Treatment of sarcoidosis. Rev. Med. Interne, 2011, 32, 109–113
Chapelon-Abric C., de Zuttere D., Duhaut P., Veyssier P., Wechsler B., Huong DL., et al., Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore), 2004, 83, 315–334
Roberts S.D., Wilkes D.S., Burgett R.A., Knox K.S., Refractory sarcoidosis responding to infliximab. Chest, 2003, 124, 2028–2031
Deng J.C., Baughman R.P., Lynch J.P. III., Cardiac involvement in sarcoidosis. Semin. Respir. Crit. Care Med., 2002, 23, 513–527
Baughman R.P., Costabel U., du Bois R.M., Treatment of sarcoidosis. Clin. Chest Med., 2008, 29, 533–548
Baughman R.P, Lower E.E, Drent M., Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them. Sarcoidosis Vasc. Diffuse Lung Dis., 2008, 2, 76–89
Greif M., Petrakopoulou P., Weiss M., Reithmann C., Reichart B., Nabauer M., et al., Cardiac sarcoidosis concealed by arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat. Clin. Pract. Cardiovasc. Med., 2008, 5, 231–236
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Solun, B., Marcoviciu, D., Belnik, Y. et al. Cardiac sarcoidosis: A review on the work-up and management. cent.eur.j.med 8, 107–116 (2013). https://doi.org/10.2478/s11536-012-0095-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11536-012-0095-8